News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,219 Results
Type
Article (46164)
Company Profile (301)
Press Release (668754)
Section
Business (208961)
Career Advice (2230)
Deals (36285)
Drug Delivery (106)
Drug Development (82547)
Employer Resources (175)
FDA (16302)
Job Trends (15230)
News (352749)
Policy (33175)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2585)
Accelerated approval (2)
Adcomms (25)
Allergies (79)
Alliances (50890)
ALS (84)
Alzheimer's disease (1351)
Antibody-drug conjugate (ADC) (110)
Approvals (16277)
Artificial intelligence (229)
Autoimmune disease (14)
Automation (14)
Bankruptcy (369)
Best Places to Work (11735)
BIOSECURE Act (19)
Biosimilars (96)
Biotechnology (221)
Bladder cancer (52)
Brain cancer (26)
Breast cancer (241)
Cancer (1873)
Cardiovascular disease (148)
Career advice (1847)
Career pathing (30)
CAR-T (143)
Cell therapy (406)
Cervical cancer (13)
Clinical research (66645)
Collaboration (758)
Compensation (417)
Complete response letters (23)
COVID-19 (2624)
CRISPR (37)
C-suite (199)
Cystic fibrosis (100)
Data (1788)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (228)
Diagnostics (6375)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (110)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (71)
Earnings (86713)
Editorial (33)
Employer branding (21)
Employer resources (152)
Events (115145)
Executive appointments (622)
FDA (17315)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (665)
Gene editing (98)
Generative AI (21)
Gene therapy (291)
GLP-1 (696)
Government (4419)
Grass and pollen (4)
Guidances (47)
Healthcare (18937)
Huntington's disease (24)
IgA nephropathy (22)
Immunology and inflammation (100)
Indications (24)
Infectious disease (2749)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (74)
Interviews (355)
IPO (16792)
IRA (42)
Job creations (3928)
Job search strategy (1589)
Kidney cancer (10)
Labor market (29)
Layoffs (461)
Leadership (17)
Legal (8103)
Liver cancer (70)
Lung cancer (267)
Lymphoma (125)
Machine learning (2)
Management (61)
Manufacturing (268)
MASH (58)
Medical device (13345)
Medtech (13350)
Mergers & acquisitions (19911)
Metabolic disorders (615)
Multiple sclerosis (63)
NASH (18)
Neurodegenerative disease (80)
Neuropsychiatric disorders (27)
Neuroscience (1822)
NextGen: Class of 2025 (6671)
Non-profit (4523)
Northern California (2286)
Now hiring (37)
Obesity (338)
Opinion (241)
Ovarian cancer (62)
Pain (77)
Pancreatic cancer (73)
Parkinson's disease (127)
Partnered (18)
Patents (188)
Patient recruitment (87)
Peanut (46)
People (58663)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20853)
Phase II (29404)
Phase III (21774)
Pipeline (864)
Podcasts (60)
Policy (109)
Postmarket research (2587)
Preclinical (8795)
Press Release (72)
Prostate cancer (86)
Psychedelics (35)
Radiopharmaceuticals (245)
Rare diseases (365)
Real estate (6255)
Recruiting (67)
Regulatory (22515)
Reports (43)
Research institute (2370)
Resumes & cover letters (376)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (65)
Series A (121)
Series B (74)
Service/supplier (14)
Sickle cell disease (53)
Southern California (1967)
Special edition (15)
Sponsored (29)
Startups (3825)
State (2)
Stomach cancer (13)
Supply chain (60)
The Weekly (41)
United States (20254)
Vaccines (667)
Venture capitalists (36)
Webinars (12)
Weight loss (236)
Women's health (30)
Worklife (16)
Date
Today (161)
Last 7 days (611)
Last 30 days (3016)
Last 365 days (34788)
2025 (6477)
2024 (36001)
2023 (40712)
2022 (51900)
2021 (56373)
2020 (54692)
2019 (47166)
2018 (35605)
2017 (33143)
2016 (32596)
2015 (38470)
2014 (33847)
2013 (28963)
2012 (29451)
2011 (30123)
2010 (28199)
Location
Africa (800)
Alabama (48)
Alaska (7)
Arizona (218)
Arkansas (12)
Asia (39615)
Australia (6656)
California (5238)
Canada (1802)
China (435)
Colorado (239)
Connecticut (253)
Delaware (119)
Europe (86211)
Florida (773)
Georgia (179)
Idaho (57)
Illinois (495)
India (23)
Indiana (284)
Iowa (7)
Japan (133)
Kansas (103)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (807)
Massachusetts (3998)
Michigan (206)
Minnesota (363)
Mississippi (2)
Missouri (72)
Montana (30)
Nebraska (26)
Nevada (55)
New Hampshire (62)
New Jersey (1505)
New Mexico (28)
New York (1494)
North Carolina (916)
North Dakota (7)
Northern California (2286)
Ohio (182)
Oklahoma (13)
Oregon (32)
Pennsylvania (1190)
Puerto Rico (6)
Rhode Island (24)
South America (1187)
South Carolina (16)
South Dakota (1)
Southern California (1967)
Tennessee (87)
Texas (772)
Utah (161)
Virginia (124)
Washington D.C. (56)
Washington State (503)
West Virginia (3)
Wisconsin (46)
715,219 Results for "kane biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to Progena
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of revyve™ Antimicrobial Wound Gel product (“revyve™”) to ProgenaCare Global LLC (“ProgenaCare”).
June 27, 2024
·
4 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Business
Kane Biotech Announces First Quarter 2024 Financial Results
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results.
May 23, 2024
·
8 min read
Kane Biotech to Host Investor Webinar
Kane Biotech Inc. announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern Time.
April 16, 2024
·
2 min read
Business
Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024
Kane Biotech Inc. will release its first quarter 2024 financial results after market close on Thursday, May 23, 2024.
May 16, 2024
·
2 min read
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map
Kane Biotech Inc. announces its intent to commercialize the patented assay which is to be named the Schultz Biofilm Wound Map in honour of the late Dr. Greg Schultz, former Professor Emeritus at the University of Florida and Chief Science Officer of Kane.
May 15, 2024
·
4 min read
Press Releases
Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology
January 22, 2025
·
4 min read
Business
Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its fourth quarter and full year 2023 financial results.
March 26, 2024
·
11 min read
Press Releases
Kane Biotech Announces Third Quarter 2024 Financial Results
November 29, 2024
·
10 min read
Press Releases
Kane Biotech Announces $3,000,000 Private Placement Offering
December 3, 2024
·
3 min read
1 of 71,522
Next
